• Abera Bioscience shifted 126,739 TO2025/2026 warrants from director Mats Wahlström to executives, staff, directors; transaction valued at SEK 1.04 million.
• CEO Maria Alriksson acquired 40,000 warrants for SEK 328,000; research chief Mats Lundberg acquired 40,000 warrants for SEK 328,000.
• Remaining 46,739 warrants were taken up by other employees and board members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abera Bioscience AB published the original content used to generate this news brief via Cision (Ref. ID: 202607200455BITN____UKPR__SV_20260720-BIT-0327-0) on July 20, 2026, and is solely responsible for the information contained therein.